British-Swedish pharmaceutical company AstraZeneca is expanding its presence in the US in a bid to boost sales in its largest market.

AstraZeneca on Monday announced plans to invest $50 billion in its US operations by 2030, a sweeping commitment that includes ...

US President Donald Trump has threatened to impose tariffs of up to 20% on drug imports to boost manufacturing in America and ...

The British pharmaceutical giant's announcement comes amid a looming deadline for increased tariffs from Washington.

British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the US amid a looming deadline of ramped ...

British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States amid a looming ...

AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the US by 2030, it said, the ...

AstraZeneca ( AZN) said it is investing $50 billion in U.S. manufacturing by 2030, following the lead of big pharma peers ...

US President Donald Trump's close aid has called for imposition of tariffs as high as 500 per cent on any country that helps Russia.

The $50 billion target, which AstraZeneca plans to meet by 2030, includes new manufacturing projects in Virginia and ...

Nuevo León continues to attract investment to its auto sector, but some companies are now skipping investment announcements, ...

Brazil's Supreme Court Justice Alexandre de Moraes approved an investigation into possible insider trading linked to the announcement of U.S. tariffs on Brazilian imports. The probe is part of a ...